What are investors reading this week? Popular on Morningstar.co.uk are articles on interest rates, the best FTSE stocks for income, and why you should check your portfolio for fund duplication. Also popular are articles on cash, gold and ESG-rated global equity funds.
Top 20 FTSE 350 Dividend Paying Stocks
UPDATED JUNE 2017: Dividend payments are expected to total £85bn in 2017. We reveal the top 20 dividend paying stocks in the FTSE 350
Fidelity's Alex Wright: 3 Undervalued UK Stocks
The manager of Morningstar Bronze rated Fidelity Special Situations gives us the lowdown on his cheapest holdings
Top 20 FTSE 100 Dividend Paying Stocks
THE INCOME INVESTOR: The largest companies in the UK source their revenues internationally, meaning your dividend stream is boosted by global economic growth
Should You Own More than One of the Same Fund?
How many UK equity income funds do you have? What about global growth? Owning multiple funds is not always a good way to diversify your portfolio
Interest Rate Rise a “Hollow Victory For Cash Savers”
While Thursday's interest rate rise is positive for cash savers, it's likely to take time to filter through to cash savers. Here are the best buys in the market today
What is the Right Amount of Cash to Hold in Your Portfolio?
How should you decide on the appropriate level of cash to hold? We believe there are several points an investor should consider
3 Investment Trusts for Inflation-Busting Income
Investment trusts are fertile hunting ground for investors seeking above-inflation yields. This trio fit the bill and are highly rated by Morningstar analysts
Funds are suitable for investors who do not have the time or expertise to construct and monitor a portfolio themselves. We go back to basics and explain all
3 Top ESG Rated Global Equity Funds
As Fundsmith launches an ESG fund for institutional investors we reveal the global equity funds which score highest on Morningstar's Sustainability Rating
Investor Views: "I Doubled My Money Investing in Gold"
Private investor Eric Vale made strong gains from gold miner Fresnillo, but has seen his pharmaceutical stocks falter